ライフサイエンスコーパス: capsule opacification

1 xis-IOL overlap, capsular folds, or anterior capsule opacification.

2 d macular oedema, glare, halos and posterior capsule opacification.

3 ve capsular bend as a deterrent to posterior capsule opacification.

4 macular oedema (CMO), cataract and posterior capsule opacification.

5 sm for the aberrant cell growth in posterior capsule opacification.

6 spikes, cystoid macular edema, and posterior capsule opacification.

7 be important in the development of posterior capsule opacification.

8 for use in longitudinal studies of posterior capsule opacification.

9 al. for precise quantification of posterior-capsule opacification.

10 may be effective in prevention of posterior capsule opacification.

11 een piggyback intraocular lenses), posterior capsule opacification and lens epithelial cell ongrowth.

12 acologic methods); 2) treatment of posterior capsule opacification; and 3) characteristics of the cap

13 ant an intraocular lens will be to posterior capsule opacification as a consequence of regenerating c

14 harp optic edges markedly decrease posterior capsule opacification as compared with round-edged impla

15 Posterior-capsule opacification, by far the most common complicati

16 Posterior capsule opacification developed in 11 eyes (57.9%), 9 ey

17 Posterior capsule opacification developed in 14 eyes (34.2%); 12 e

18 Evaluation of Posterior Capsule Opacification (EPCO) image analysis software was

19 roillumination using evaluation of posterior capsule opacification (EPCO) software.

20 rest are techniques for inhibiting posterior capsule opacification in pediatric patients by optic cap

21 psulorhexis is required to inhibit posterior-capsule opacification in pediatric patients; work by Nis

22 , which may decrease resistance to posterior capsule opacification in the face of a regenerating cort

23 result in different entities, e.g. anterior capsule opacification, interlenticular opacification (be

24 Posterior capsule opacification is a frequent postoperative proble

25 Posterior capsule opacification is also potentially solvable with

26 Posterior capsule opacification is an ongoing cellular redistribut

27 Posterior capsule opacification is the most frequent late complica

28 Posterior capsule opacification occurred in 66 eyes (82.5%), and 4

29 in the percentage area covered by posterior capsule opacification over time.

30 o objectively assess the long-term posterior capsule opacification (PCO) and neodymium-doped yttrium

31 Posterior capsule opacification (PCO) arises because of a persiste

32 in intraocular lens (IOL) design, posterior capsule opacification (PCO) arising from lens cell growt

33 The fibrotic lens disorder posterior capsule opacification (PCO) develops in millions of pati

34 his resilient growth gives rise to posterior capsule opacification (PCO) in a significant proportion

35 Posterior capsule opacification (PCO) is a complication of catarac

36 Posterior capsule opacification (PCO) is the most common complicat

37 Posterior capsule opacification (PCO) is the most common post-oper

38 is common, routine and effective, posterior capsule opacification (PCO) occurs in 30-50% of patients

39 dually develop the complication of posterior capsule opacification (PCO) or secondary cataract.

40 determine the 5-year incidence of posterior capsule opacification (PCO) requiring Nd:YAG laser capsu

41 dophakic patients with symptomatic posterior capsule opacification (PCO) underwent Nd:YAG laser capsu

42 a wound-healing response, known as posterior capsule opacification (PCO), following cataract surgery.

43 ar migration, thus contributing to posterior capsule opacification (PCO).

44 eta2 antibody in a rodent model of posterior capsule opacification (PCO).

45 using an in vitro culture model of posterior capsule opacification (PCO).

46 omplication of cataract surgery is posterior capsule opacification (PCO; secondary cataract).

47 his can cause blindness because of posterior capsule opacification, proliferative vitroretinopathy, f

48 ing for a more rapid assessment of posterior capsule opacification resistance.

49 appreciably improves resistance to posterior capsule opacification, significant factors remain under

50 alyzed for PCO using Evaluation of Posterior Capsule Opacification software.

51 review addresses 1) inhibition of posterior capsule opacification (surgical techniques, intraocular

52 s exchange suggest higher rates of posterior capsule opacification than with standard cataract surger

53 le width in pseudophakic eyes with posterior capsule opacification were measured with anterior segmen